Last updated: 24 May 2021 at 5:23pm EST

Juan Ramon Alaix Net Worth

The estimated Net Worth of Juan Ramon Alaix is at least $56.1 Millón dollars as of 20 May 2021. Juan Alaix owns over 130 units of Zoetis Inc stock worth over $40,872,359 and over the last 12 years Juan sold ZTS stock worth over $15,180,459.

Juan Alaix ZTS stock SEC Form 4 insiders trading

Juan has made over 12 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Juan exercised 130 units of ZTS stock worth $24,699 on 20 May 2021.

The largest trade Juan's ever made was exercising 353,940 units of Zoetis Inc stock on 14 January 2021 worth over $67,245,061. On average, Juan trades about 24,811 units every 14 days since 2013. As of 20 May 2021 Juan still owns at least 215,129 units of Zoetis Inc stock.

You can see the complete history of Juan Alaix stock trades at the bottom of the page.

What's Juan Alaix's mailing address?

Juan's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.

Insiders trading at Zoetis Inc

Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio y Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.

What does Zoetis Inc do?

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.

Complete history of Juan Alaix stock trades at Zoetis Inc

Persona	Trans. Transacción	Precio total
Juan Ramon Alaix Director	Uso de opción	$22,854 20 May 2021
Juan Ramon Alaix Director	Uso de opción	$9,746,047 19 Feb 2021
Juan Ramon Alaix Director	Uso de opción	$15,389,334 13 Feb 2021
Juan Ramon Alaix Director	Uso de opción	$56,970,182 14 Jan 2021
Juan Ramon Alaix Director	Venta	$15,180,459 13 Nov 2020
Juan Ramon Alaix Director	Uso de opción	$13,272,644 3 Mar 2020
Juan Ramon Alaix Director	Uso de opción	$5,146,294 21 Feb 2020
Juan Ramon Alaix Director	Uso de opción	$3,861,005 19 Feb 2020
Juan Ramon Alaix Director	Uso de opción	$2,304,500 19 Nov 2019
Juan Ramon Alaix Director	Uso de opción	$9,641,047 27 Feb 2019
Juan Ramon Alaix Director	Uso de opción	$3,907,956 8 Nov 2018
Juan Ramon Alaix Director	Uso de opción	$3,510,000 14 Aug 2018

Zoetis Inc executives and stock owners

Zoetis Inc executives and other stock owners filed with the SEC include:

Glenn David,
Chief Financial Officer, Executive Vice President
Kristin Peck,
Chief Executive Officer, Director
Catherine Knupp,
Executive Vice President, President - Research and Development
Kristin C. Peck,
CEO & Director
Wafaa Mamilli,
Exec. VP and Chief Information & Digital Officer
Roman Trawicki,
Exec. VP and Pres of Global Manufacturing & Supply
Glenn C. David,
Exec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance
Michael McCallister,
Non-Executive Independent Chairman of the Board
Robert Scully,
Independent Director
Gregory Norden,
Independent Director
Paul Bisaro,
Independent Director
William Steere,
Independent Director
Linda Rhodes,
Independent Director
Willie Reed,
Independent Director
Louise Parent,
Independent Director
Sanjay Khosla,
Independent Director
Frank D'Amelio,
Independent Director
Roman Trawicki,
Executive Vice President, President - Global Manufacturing and Supply
Heidi Chen,
Executive Vice President, General Counsel, Corporate Secretary
Roxanne Lagano,
Chief Human Resource Officer, Executive Vice President and Global Operations
Heidi C. Chen,
Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics
Roxanne Lagano,
Exec. VP and Chief HR Officer & Global Operations
Wetteny N. Joseph,
Exec. VP & CFO
Timothy J. Bettington,
Exec. VP and Pres of U.S. Operations & Global Customer Experience
William Price,
VP & Chief Communications Officer
Steven Frank,
VP of Investor Relations
Gavin Hattersley,
Director
Robert Edward Kelly,
Executive Vice President
Alejandro Bernal,
Executive Vice President
Juan Ramon Alaix,
Director
Clinton A. Jr. Lewis,
Executive Vice President
Sherry N Pudloski,
Executive Vice President
Robert J Polzer,
Executive Vice President
Amy W Schulman,
Director
Sandra J. Beaty,
Executive Vice President
Joyce J. Lee,
Executive Vice President
Douglas E. Giordano,
Director
William F Doyle,
Inc Pfizer,
Director
Square Capital Management, ...,
Stefan Weiskopf,
Executive Vice President
Richard A. Passov,
EVP, Chief Financial Officer
Paul Herendeen,
Exec. V.P. and CFO
Charles H Hill,
Director
Geno J Germano,
Director
Andrew Fenton,
Executive Vice President
James Michael Mc Farland,
Executive Vice President
Wafaa Mamilli,
Executive Vice President
Timothy J Bettington,
Executive Vice President
Antoinette Renee Leatherberry,
Director
Astorga Jeannette Ferran,
Executive Vice President
Abhay U Nayak,
Executive Vice President
Wetteny Joseph,
Chief Financial Officer
Rimma Driscoll,
Executive Vice President
Vanessa Broadhurst,
Director
Jamie Brannan,
Executive Vice President
Nicholas Ashton,
Executive Vice President
Soria Ester Banque,
Executive Vice President